Your browser doesn't support javascript.
loading
Identification of International Society on Thrombosis and Haemostasis major and clinically relevant non-major bleed events from electronic health records: a novel algorithm to enhance data utilisation from real-world sources.
Hartenstein, Alexander; Abdelgawwad, Khaled; Kleinjung, Frank; Privitera, Stephen; Viethen, Thomas; Vaitsiakhovich, Tatsiana.
Afiliação
  • Hartenstein A; Medical Affairs and Pharmacovigilance, Bayer AG, Berlin, Germany.
  • Abdelgawwad K; Medical Affairs and Pharmacovigilance, Bayer AG, Berlin, Germany.
  • Kleinjung F; Medical Affairs and Pharmacovigilance, Bayer AG, Berlin, Germany.
  • Privitera S; Medical Affairs and Pharmacovigilance, Bayer AG, Berlin, Germany.
  • Viethen T; Research and Development, Bayer AG, Wuppertal, Germany.
  • Vaitsiakhovich T; Medical Affairs and Pharmacovigilance, Bayer AG, Berlin, Germany.
Int J Popul Data Sci ; 8(1): 2144, 2023.
Article em En | MEDLINE | ID: mdl-38414540
ABSTRACT

Introduction:

In randomised controlled trials (RCTs), bleeding outcomes are often assessed using definitions provided by the International Society on Thrombosis and Haemostasis (ISTH). Information relating to bleeding events in real-world evidence (RWE) sources are not identified using these definitions. To assist with accurate comparisons between clinical trials and real-world studies, algorithms are required for the identification of ISTH-defined bleeding events in RWE sources.

Objectives:

To present a novel algorithm to identify ISTH-defined major and clinically-relevant non-major (CRNM) bleeding events in a US Electronic Health Record (EHR) database.

Methods:

The ISTH definition for major bleeding was divided into three subclauses fatal bleeds, critical organ bleeds and symptomatic bleeds associated with haemoglobin reductions. Data elements from EHRs required to identify patients fulfilling these subclauses (algorithm components) were defined according to International Classification of Diseases, 9th and 10th Revisions, Clinical Modification disease codes that describe key bleeding events. Other data providing context to bleeding severity included in the algorithm were 'interaction type' (diagnosis in the inpatient or outpatient setting), 'position' (primary/discharge or secondary diagnosis), haemoglobin values from laboratory tests, blood transfusion codes and mortality data.

Results:

In the final algorithm, the components were combined to align with the subclauses of ISTH definitions for major and CRNM bleeds. A matrix was proposed to guide identification of ISTH bleeding events in the EHR database. The matrix categorises bleeding events by combining data from algorithm components, including diagnosis codes, 'interaction type', 'position', decreases in haemoglobin concentrations (≥ 2 g/dL over 48 hours) and mortality.

Conclusions:

The novel algorithm proposed here identifies ISTH major and CRNM bleeding events that are commonly investigated in RCTs in a real-world EHR data source. This algorithm could facilitate comparison between the frequency of bleeding outcomes recorded in clinical trials and RWE. Validation of algorithm performance is in progress.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose / Registros Eletrônicos de Saúde Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose / Registros Eletrônicos de Saúde Idioma: En Ano de publicação: 2023 Tipo de documento: Article